Yuanke Liang

1.1k citations

30 papers · 752 indexed · h-index 16

Cancer Research top 10%
Oncology top 10%
- Cancer Cells and Metastasis 10
Molecular Biology
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 3
- Developmental Biology and Gene Regulation 3
- Hedgehog Signaling Pathway Studies 2
Cell Biology
- Cellular transport and secretion 2
Pulmonary and Respiratory Medicine
- Metastasis and carcinoma case studies 2
Biomedical Engineering
- Nanoplatforms for cancer theranostics 4

Co-authors: Haoyu Lin De Zeng Chunfa Chen Xiaolong Wei Guo‐Jun Zhang Yingsheng Xiao Jing‐Wen Bai Frank A.E. Kruyt
Cited by: Cancer Research Oncology Molecular Biology
Journals: PLoS ONE (1 paper)Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
Partner nations: China Netherlands Hong Kong

In The Last Decade

Yuanke Liang

28 papers receiving 741 citations

Peers

Countries citing papers authored by Yuanke Liang

Since Specialization

Citations

This map shows the geographic impact of Yuanke Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanke Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanke Liang more than expected).

Fields of papers citing papers by Yuanke Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanke Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanke Liang. The network helps show where Yuanke Liang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuanke Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuanke Liang Line = papers co-authored together Yuanke Liang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Enhancing medical English proficiency: the current status and development potential of peer-assisted learning in medical education BMC Medical Education ·Peixin Lin,Yue-xin CAI,Sijia He,Xinxin Li,Yuanke Liang,Tian Huang,Juanyun Li,Baohang Lin,Gang Xin,Haoyu Lin	2025	1
2	RC48-targeted two-dimensional black phosphorus nanoplatform for precise photothermal-immunotherapy of HER2-positive breast cancer Journal of Colloid and Interface Science ·Feiyang Xiao,Guan‐Yuan Chen,Hongwei Lü,Xinrui Li,Shuzhao Chen,Ziyang Lin,Wen‐Xiu Ni,Ruiqian Yang,Xinqiang Fang,Haoyu Lin,Benqing Zhou,Yuanke Liang	2025	0
3	RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities Critical Reviews in Oncology/Hematology ·Shimeng Wang,Hexing Sun,Guan‐Yuan Chen,Chengyu Wu,Bingmei Sun,Jiajia Lin,Danping Lin,De Zeng,Baohang Lin,Guan Huang,Xiaofeng Lu,Haoyu Lin,Yuanke Liang	2024	4
4	Abstract 1549: Molecular mechanism of CD146 nanobody in tumor metastasis inhibition mediating by IL-6/JAK/STAT3 signaling in triple-negative breast cancer Cancer Research ·Kaiyuan Huang,Hexing Sun,Chengyu Wu,Danping Lin,Jinling Chen,Yanhan Chen,Xinqiang Fang,Shuzhao Chen,Yuanke Liang,Haoyu Lin	2024	0
5	HER2-targeting two-dimensional black phosphorus as a nanoplatform for chemo-photothermal therapy in breast cancer Materials Today Bio ·Yuanke Liang,Jinxing Liu,Cong Zhao,Hexing Sun,Kaiyuan Huang,Qin Xie,De Zeng,Haoyu Lin,Benqing Zhou	2023	6
6	Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model Frontiers in Public Health ·Zhaomin Xie,Joseph T. F. Lau,Yuanke Liang,Qiaolei Ouyang,Junjia Chen,Si Lin,Kaitao Yao,Xuanyin Hu,Haoyu Lin,Yanqiu Yu,De Zeng	2023	1
7	Online short videos promoting public breast cancer literacy: a pretest-posttest control group trial on efficiency, attitude, and influencing factors Frontiers in Public Health ·Qian-Rui Xu,Peizhu Wu,Jia-Zi Du,Wen-Jun Zhuang,Xiaotong He,Yongyong Ma,De Zeng,Yuanke Liang,Xiaoyang Xu,Lei Xie,Haoyu Lin	2023	10
8	Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy Frontiers in Oncology ·Liyun Xie,Kun Wang,Hai-Lu Chen,Yanxia Shi,Yuanqi Zhang,Haoyu Lin,Yuanke Liang,Yingsheng Xiao,Zhiyong Wu,Zhongyu Yuan,Si-Qi Qiu	2022	6
9	CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells Cancer Letters ·Yuanke Liang,Xiaoling Zhou,Qin Xie,Hexing Sun,Kaiyuan Huang,Huan Chen,Wende Wang,Benqing Zhou,Xiaolong Wei,De Zeng,Haoyu Lin	2022	23
10	CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling Cellular and Molecular Life Sciences ·Yuanke Liang,Daniëlle C. Voshart,Judith T.M.L. Paridaen,Nynke Oosterhof,Liang Dong,Arun Thiruvalluvan,Inge S. Zuhorn,Wilfred F.A. den Dunnen,Guo‐Jun Zhang,Haoyu Lin,Lara Barazzuol,Frank A.E. Kruyt	2022	27
11	Associations of Obesity, Physical Activity, and Screening With State-Level Trends and Racial and Ethnic Disparities of Breast Cancer Incidence and Mortality in the US JAMA Network Open ·Zhaomin Xie,Wei Xie,Yuanke Liang,Haoyu Lin,Jundong Wu,Yukun Cui,Xuefen Su,De Zeng	2022	6
12	Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN Cell Death and Disease ·Yong‐Qu Zhang,Yuanke Liang,Yang Wu,Min Chen,Weiling Chen,Ronghui Li,Yun‐Zhu Zeng,Wen‐He Huang,Jundong Wu,De Zeng,Wen‐Liang Gao,Chunfa Chen,Haoyu Lin,Ruiqin Yang,Jiang-Wen Zhu,Wan‐Ling Liu,Jing‐Wen Bai,Min Wei,Xiaolong Wei,Guo‐Jun Zhang	2021	34
13	CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer Frontiers in Oncology ·Yuanke Liang,Ze-kun- Deng,Mu-tong CHEN,Si-Qi Qiu,Yingsheng Xiao,Yuzhu Qi,Qin Xie,Zheng-hao Wang,Shicheng Jia,De Zeng,Haoyu Lin	2021	40
14	FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer Cancer Cell International ·Qin Xie,Yingsheng Xiao,Shicheng Jia,Jie-xuan ZHENG,Zhen-chao DU,Yi‐Chun Chen,Mu-tong CHEN,Yuanke Liang,Haoyu Lin,De Zeng	2020	16
15	O-6-methylguanine DNA methyltransferase is a favorable biomarker with proliferation suppressive potential in Breast Cancer Journal of Cancer ·Danxia Lin,Yingsheng Xiao,Bin-Liang Huang,Xiao Wu,Chunfa Chen,Yuanke Liang,De Zeng	2020	4
16	Notch3 inhibits epithelial–mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression Oncogenesis ·Haoyu Lin,Yuanke Liang,Xiaowei Dou,Chunfa Chen,Xiaolong Wei,De Zeng,Jing‐Wen Bai,Yuxian Guo,Fang-Fang Lin,Wen-Jia Chen,Caiwen Du,Yaochen Li,Min Chen,Guo‐Jun Zhang	2018	35
17	Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells Cancer Letters ·Yingsheng Xiao,De Zeng,Yuanke Liang,Yang Wu,Meifang Li,Yuzhu Qi,Xiaolong Wei,Wen-Jia Chen,Min Chen,Guo‐Jun Zhang	2018	51
18	MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines npj Breast Cancer ·Yuanke Liang,Haoyu Lin,Xiaowei Dou,Min Chen,Xiaolong Wei,Yong‐Qu Zhang,Yang Wu,Chunfa Chen,Jing‐Wen Bai,Yingsheng Xiao,Yuzhu Qi,Frank A.E. Kruyt,Guo‐Jun Zhang	2018	58
19	Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α Theranostics ·Xiaowei Dou,Yuanke Liang,Haoyu Lin,Xiaolong Wei,Yong‐Qu Zhang,Jing‐Wen Bai,Chunfa Chen,Min Chen,Caiwen Du,Yaochen Li,Jie Tian,Kwan Man,Guo‐Jun Zhang	2017	50
20	MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial–mesenchymal transition, decreased ERα expression and AKT activation Cancer Letters ·Yuanke Liang,De Zeng,Yingsheng Xiao,Yang Wu,Yan-Xiu Ouyang,Min Chen,Yaochen Li,Haoyu Lin,Xiaolong Wei,Yong‐Qu Zhang,Frank A.E. Kruyt,Guo‐Jun Zhang	2016	57

About Yuanke Liang

Yuanke Liang is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 30 papers that have together received 752 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Epigenetics and DNA Methylation (5 papers), Nanoplatforms for cancer theranostics (4 papers), Cancer-related gene regulation (3 papers), Developmental Biology and Gene Regulation (3 papers), Hedgehog Signaling Pathway Studies (2 papers), Metastasis and carcinoma case studies (2 papers) and Cellular transport and secretion (2 papers). The work is most often cited by research in Cancer Research (238 citations), Oncology (249 citations) and Molecular Biology (488 citations). Yuanke Liang has collaborated with scholars based in China, Netherlands and Hong Kong. Frequent co-authors include Haoyu Lin, De Zeng, Chunfa Chen, Xiaolong Wei, Guo‐Jun Zhang, Yingsheng Xiao, Jing‐Wen Bai, Frank A.E. Kruyt, Yong‐Qu Zhang and Yang Wu. Their work appears in journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact